About
Mr. Stuart A. Randle, also known as Stu, has been the Chief Executive Officer of Fluidnet Corporation since January 6, 2016. He served as an Independent Director at Comera Life Sciences Holdings, Inc. from June 2021 until August 31, 2023. He has been Director of Comera Life Sciences, Inc. since June 2021. Mr. Randle serves as an Advisor of Cutlass Capital, LLC. Mr. Randle served as the Chief Executive Officer and President of GI Dynamics Inc. from February 2004 to September 18, 2014. He has experience in the life sciences industry in engineering, sales, marketing, senior management and leadership roles in developing companies and also divisions of major medical corporations. He also served as an Entrepreneur-in-Residence at Advanced Technology Ventures. Before ATV, from 1998 to 2001, he served as the President, Chief Executive Officer and Director of ACT Medical, Inc., where he was responsible for developing and executing a new strategy that resulted in the merger with MedSource Technologies, Inc. in 2001. Before 1998, Mr. Randle was responsible for the northeastern region of the United States for Allegiance Healthcare Corporation. From 1996 to 1998, Mr. Randle served as the Corporate Vice President and President of the Northeast Region at Allegiance Corporation.
Before that, he was a Corporate Officer of Cardinal Health 200, LLC (formerly, Allegiance Healthcare Corporation), where he helped plan and execute the spin-off from Baxter International in 1996. Since December 2015, he has been the President & Chief Executive Officer of Ivenix, Inc. until January 2020. He joined Baxter Healthcare Corp. as a Group Marketing Manager for the Renal Division. He served as Vice President of Sales at IV Therapy, General Manager at the Anesthesia Division and the President of the Northeast Region, managing the business. He spent many years with Baxter and was also responsible for launching the world’s first needle-less IV system, growing its sales. Before that, he served as the President of the New England Region at Baxter Healthcare Corporation from 1993 to 1998. From 2003 to 2004, he served as Interim Chief Executive Officer of Optobionics Corporation, a medical device company. Mr. Randle has also held various sales and engineering roles with Ingersoll-Rand Corporation. He began his career at Ingersoll-Rand, in 2009, where Mr. Randle served as the Sales and Application Engineer as well as a Distribution Manager.
He was the Independent Director of Flex Pharma, Inc. from October 2014 until July 2019 and was its Lead Independent Director until July 2019. Mr. Randle serves as a Member of the Board of Directors of Ivenix, Inc. He has been a Director at Teleflex Incorporated since May 2009 and Beacon Roofing Supply, Inc. since February 27, 2006. Mr. Randle serves as Lead Independent Director at Beacon Roofing Supply, Inc. and is Independent Non-Executive Chairman from August 01, 2023. He served as Director of GI Dynamics Inc. from 2003 to November 5, 2014. He served as Director of Baxter Healthcare Corporation. He served as Director of Specialized Health Products International, Inc. since 2001. He serves as a Member of the Advisory Board at Echelon Ventures. He serves on the board of ReForm Biologics, Inc. He has many years of biomedical experience. Mr. Randle holds a B.S. in Mechanical Engineering from Cornell University and an M.B.A. from the J. L. Kellogg Graduate School of Management at Northwestern University.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
 | Board | Other Non-Executive | 01/06/2021 |
 | Board | Chairperson | 01/08/2023 |
 | Board | Other Non-Executive | 01/01/2001 |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Teleflex | Board | Member | 01/01/2009 | |
| Teleflex | Remuneration | Chairperson | 01/01/2009 | |
| Teleflex | Nominations & Governance | Member | 01/01/2009 |